Vident Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.24M | Buy |
18,500
+2,422
| +15% | +$1.08M | 0.09% | 189 |
|
|
2025
Q1 | $7.79M | Sell |
16,078
-3,756
| -19% | -$1.82M | 0.11% | 170 |
|
|
2024
Q4 | $7.99M | Buy |
19,834
+11,476
| +137% | +$4.62M | 0.14% | 154 |
|
|
2024
Q3 | $3.89M | Buy |
8,358
+362
| +5% | +$168K | 0.1% | 211 |
|
|
2024
Q2 | $3.75M | Sell |
7,996
-43,531
| -84% | -$20.4M | 0.1% | 202 |
|
|
2024
Q1 | $21.5M | Buy |
51,527
+7,347
| +17% | +$3.07M | 0.45% | 44 |
|
|
2023
Q4 | $18M | Sell |
44,180
-4,396
| -9% | -$1.79M | 0.45% | 44 |
|
|
2023
Q3 | $16.9M | Buy |
+48,576
| New | +$16.9M | 0.52% | 37 |
|